NCT01511744View on ClinicalTrials.gov

Phase IV Clinical Trial of an Inactivated Influenza Split Vaccine

PHASE4CompletedINTERVENTIONAL
Enrollment

6,000

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

November 30, 2011

Study Completion Date

March 31, 2012

Conditions
Human Influenza
Interventions
BIOLOGICAL

Inactivated influenza split vaccine

3000 participants (750 of above 60,750 of age 19-60, 750 of age 13-18 and 750 of age 3-12) to receive influenza split vaccine of 15 μg HA; one dose regime

Trial Locations (1)

Unknown

Henan Province Center for Disease Preventionand Control, Zhengzhou

Sponsors
All Listed Sponsors
lead

Hualan Biological Engineering, Inc.

INDUSTRY